We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+10.15%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.23B
AUM Growth
+$348M
Cap. Flow
+$172M
Cap. Flow %
7.72%
Top 10 Hldgs %
19.36%
Holding
1,755
New
109
Increased
939
Reduced
649
Closed
58

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$14.5M
2
AMGN icon
Amgen
AMGN
+$11.6M
3
ABBV icon
AbbVie
ABBV
+$10.2M
4
CELG
Celgene Corp
CELG
+$8.88M
5
BIIB icon
Biogen
BIIB
+$7.99M

Sector Composition

Rank Sector Weight
1 Healthcare 24.35%
2 Technology 12.32%
3 Financials 9.33%
4 Industrials 8.44%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFF icon
926
International Flavors & Fragrances
IFF
$19.4B
$584K 0.03%
6,798
+498
+8% +$42.2K
GWW icon
927
W.W. Grainger
GWW
$65.3B
$583K 0.03%
2,284
+507
+29% +$132K
HOMB icon
928
Home BancShares
HOMB
$6.21B
$583K 0.03%
31,240
+8,020
+35% +$138K
SGY
929
DELISTED
Stone Energy
SGY
$583K 0.03%
297
-255
-46% -$488K
CLB icon
930
Core Laboratories
CLB
$538M
$580K 0.03%
3,036
+68
+2% +$12.7K
LUV icon
931
Southwest Airlines
LUV
$22.1B
$580K 0.03%
30,793
+6,631
+27% +$116K
MOH icon
932
Molina Healthcare
MOH
$10.3B
$580K 0.03%
16,698
-792
-5% -$26.7K
GK
933
DELISTED
G&K Services Inc
GK
$580K 0.03%
9,322
-3,343
-26% -$202K
ATML
934
DELISTED
ATMEL CORP
ATML
$580K 0.03%
74,137
+1,493
+2% +$10.9K
KEY icon
935
KeyCorp
KEY
$24.3B
$578K 0.03%
43,088
-3,644
-8% -$46.1K
NEOG icon
936
Neogen
NEOG
$2.05B
$578K 0.03%
33,712
+8,624
+34% +$150K
SNBR
937
DELISTED
Sleep Number
SNBR
$578K 0.03%
27,394
+13,582
+98% +$285K
PKY
938
DELISTED
Parkway, Inc.
PKY
$576K 0.03%
29,885
+9,501
+47% +$171K
LPS
939
DELISTED
LENDER PROCESSING SERVICES INC
LPS
$576K 0.03%
15,422
+1,411
+10% +$48.9K
ACIW icon
940
ACI Worldwide
ACIW
$5.72B
$575K 0.03%
26,517
+2,148
+9% +$42.6K
FCFS icon
941
FirstCash
FCFS
$8.55B
$575K 0.03%
9,299
+2,393
+35% +$145K
AKRX
942
DELISTED
Akorn Inc
AKRX
$574K 0.03%
23,318
+6,036
+35% +$136K
CIEN icon
943
Ciena
CIEN
$55.3B
$572K 0.03%
23,883
+2,705
+13% +$64.4K
DORM icon
944
Dorman Products
DORM
$4.01B
$570K 0.03%
10,170
+2,630
+35% +$132K
TTI icon
945
TETRA Technologies
TTI
$1.23B
$570K 0.03%
46,084
-3,671
-7% -$45.7K
CMS icon
946
CMS Energy
CMS
$23.1B
$568K 0.03%
21,231
+397
+2% +$10.7K
NSIT icon
947
Insight Enterprises
NSIT
$3.55B
$568K 0.03%
25,011
-1,524
-6% -$33.4K
APH icon
948
Amphenol
APH
$188B
$567K 0.03%
50,840
+12,784
+34% +$132K
PSB
949
DELISTED
PS Business Parks, Inc.
PSB
$567K 0.03%
7,425
+998
+16% +$77.6K
MXIM
950
DELISTED
Maxim Integrated Products
MXIM
$567K 0.03%
20,317
+1,553
+8% +$44.9K

Similar funds

Profund Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Profund Advisors held 1,755 positions worth $2.23B, up 18% from $1.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Profund Advisors deployed $172M of net new capital in Q4 2013, opening 109 new positions and adding to 939 existing holdings. Its largest new stake was Ambev: 287,712 shares worth $2.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was ARM HOLDINGS PLC ADS, an estimated $2.18M trimmed.

  • Profund Advisors's largest Q4 2013 buy was Ambev: 287,712 shares worth $2.12M.
  • Profund Advisors added most to Gilead Sciences in Q4 2013, an estimated $14.5M increase.
  • Profund Advisors's biggest Q4 2013 reduction was ARM HOLDINGS PLC ADS, cutting an estimated $2.18M.
  • Profund Advisors fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $2.1M.
  • Profund Advisors's ten largest holdings make up 19% of its $2.23B portfolio in Q4 2013.
  • Profund Advisors opened 109 new positions and closed 58 in Q4 2013.
  • Profund Advisors's portfolio value rose 18% quarter-over-quarter to $2.23B.

Based on Profund Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.